Protagenic Therapeutics, Inc. financial statements
Protagenic Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 0 | 10-K |
| Net income | USD 1.37M | 10-K |
| Cash and equivalents | USD 1.51M | 10-Q |
Protagenic Therapeutics, Inc. financials on 6ix · Protagenic Therapeutics, Inc. on 6ix